Prediction: Disney Will Beat the Market. Here's Why.fool.comAfter finally meeting the market in 2024, the House of Mouse is ready to beat the market in 2025.
NextEra Energy: Revenue Falls Short 29%fool.comNextEra Energy reported mixed earnings for Q4 2024, meeting EPS expectations but missing on revenue.
SK Hynix Shared Great Insight for Micron and Nvidia Stock Investorsfool.comSK Hynix continues to see strong demand for HBM solutions thanks to AI accelerators.
HCA Healthcare Misses EPS, Revenue Upfool.comHCA Healthcare reported solid revenue growth in Q4, but faced challenges, missing its earnings per share estimates due to hurricane impacts.
Verizon: EPS and Revenue Top Forecastsfool.comVerizon Communications reported solid fourth-quarter earnings driven by robust wireless service revenue growth and strong free cash flow.
Wall Street Analysts Say This Quantum Computing Stock Could Soar 45% in 2025fool.comMany quantum computing stocks have risen well above Wall Street's price targets, but this one still has room to climb.
American Express Q4 EPS Beats Estimatesfool.comAmerican Express posted record Q4 revenue and earnings while also beating analysts' expectations.
How Mergers and Acquisitions Impact Investorsfool.comThere are many reasons why executives might pursue a merger or acquisition.
Should You Forget Nvidia and Buy This Tech Stock Instead?fool.comLooking for the next big thing in AI and tech stocks? Check out why one supporting player might be a better pick than the usual household name.
This Chip Stock Could Yield Substantial Returns, but Is It Worth the Risk?fool.comWolfspeed continues to burn cash as it invests in improving its manufacturing capabilities, which could be a massive growth driver.
Where Will Sun Communities Stock Be in 3 Years?fool.comThis sleepy REIT faces tougher near-term challenges than its industry peers.
Should You Buy Visa Stock While It's Below $378?fool.comWall Street's bulls expect the card processor's stock to head even higher.
Should You Buy XRP While It's Under $4?fool.comXRP has skyrocketed recently, but how much higher can it soar? Here's what you need to know.
Is AbbVie Stock a Buy?fool.comAlthough AbbVie has lost patent exclusivity for its flagship drug, Humira, the company may soon be bigger and better.
Why I'm Not Opening Any CDs in 2025 -- Even With Rates Over 4%fool.comThere are better places for me to put my money than CDs. Find out what they are and what makes them great.
5 of the Safest High-Yield Dividend Stocks You Can Confidently Buy for 2025fool.comFive magnificent income stocks -- sporting an average yield of 4.26% -- can pad investors' pocketbooks in the new year (and well beyond).
